Medical Radiation Shielding Market

Medical Radiation Shielding Market by Products (Shields, Booths, Lead sheet, Doors, Windows, Curtain, X-Ray), Solution (Radiation Therapy, Cyclotron, PET, CT, MRI), End-user (Hospitals, Clinics, ASCs, Diagnostic Center), & Region - Global Forecast to 2028

Report Code: MD 4508 Aug, 2023, by marketsandmarkets.com

The global medical radiation shielding market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, Growing incidences of cancer, and Increasing safety awareness among people working in radiation-prone environments.

Attractive Opportunities in the Medical Radiation Shielding Market

Medical Radiation Shielding Market

To know about the assumptions considered for the study, Request for Free Sample Report

Medical Radiation Shielding Market

Medical Radiation Shielding Dynamics

DRIVER: Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment

Nuclear medicine & radiotherapy have a wide range of applications in cancer treatment; thus, the increasing prevalence of the disease will favor the radiation detection, monitoring, and safety market. According to GLOBOCAN, the number of cancer cases will rise to ~30 million by 2040 from 19.3 million in 2020. More than 60% of new cancer cases occur in Africa, Asia, and Central & South America; 70% of global cancer deaths also occur in these regions. According to the World Nuclear Association, more than 40 million nuclear medicine procedures are performed every year, and the demand for radioisotopes has increased by 5% annually (data as of May 2020). Nearly 10,000 hospitals across the globe use radioisotopes. In the US, more than 20 million nuclear medicine procedures are performed yearly. In April 2022, According to the World Nuclear Association, North America dominated the diagnostic radioisotopes market and accounted for 50% of the market share, and Europe accounted for 20%.

According to NHS England 2020, Radiography (X-ray) was the most common imaging test performed, with 22.9 million procedures, followed by diagnostic ultrasonography (9.51 million procedures), computerized axial tomography (5.15 million procedures), and MRI (3.46 million procedures). The increasing use of radiation therapy is expected to drive the adoption of medical radiation shielding products market.

RESTRAINTS: Lack of adequate healthcare infrastructure

Radiotherapy devices are larger in size and require ample space for installation. One of the major factors restraining the adoption of medical radiation shielding systems is the lack of adequate healthcare infrastructure due to limited healthcare expenditure. In underdeveloped and developing countries very few healthcare institutions are able to utilize the medical radiation shielding solutions for cancer treatment. This, in turn, limits the number of radiotherapy procedures despite their high demand. According to the National Association for Proton Therapy, over 170,000 patients have received proton therapy worldwide, with over 75,000 in the US. By 2030, it is estimated that between 300,000 and 600,000 patients will have received proton therapy treatment. Although clinical experience with proton therapy is increasing now, only approximately 1% of all radiation therapy recipients receive proton therapy, and prospective randomized studies involving large sample populations remain very limited. Most high-income countries have at least one radiotherapy unit available for every 250,000 people. This, on average, would mean four radiotherapy machines per million population.

OPPORTUNITY: Rising healthcare expenditure across developing countries

The increasing healthcare expenditure in several emerging countries, such as China, India, Brazil, and Mexico, will improve access to quality healthcare in these countries. The rising incidence of cancer in these countries will drive the demand for medical radiation shielding products.

The increase in per-capita healthcare expenditure and the raising public demand for cost effective healthcare services can boost the demand of the healthcare products like  oncology devices across the developing countries. The overall increase in healthcare expenditure can evidence this. For example, in the Economic Survey of 2022, India’s public expenditure on healthcare stood at 2.1% of GDP in 2021-22 against 1.8% in 2020-21 and 1.3% in 2019-20 (Source: IBEF). Whereas, in China, healthcare expenditure has increased by 12.6% to USD 930 billion as the government has raised spending in the healthcare sector. (Source: Healthcare Asia).

In addition, the developing medical tourism industry in emerging economies and competitive surgical procedure costs offered by prominent healthcare facilities are also increasing the adoption of healthcare technologies in these markets, including oncology. Healthcare treatments cost 65% to 80% less in Malaysia than in the US (Source: Medical Tourism Malaysia). Malaysia’s medical tourism has been growing between 16% and 17% year-on-year over the last five years, outperforming the global industry’s average growth of between 10% and 12%. India is another key hub for medical tourism. Due to the low-cost treatments available in India, the country ranks number 7 among the 20 wellness tourism markets, with over 56 million trips made to India for medical value tourism generating USD 16.3 billion in revenue. It also ranks number 3 in wellness-focused countries in the Asia Pacific.

The large target patient population, untapped opportunities, and low competition in developing economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the medical radiation shielding market.

CHALLENGE: High cost of lead in manufacturing radiation accessories

Lead is the most important raw material required to manufacture radiation safety accessories such as gloves, aprons, and eyewear. However, it is extensively used for other purposes, such as fire protection and manufacturing lead storage batteries.

The cost of implementing radiation shielding measures can be a significant restraint. Radiation shielding materials, construction modifications, and specialized equipment can be expensive, especially for smaller healthcare facilities or those with budget constraints. The upfront costs associated with radiation shielding products may deter some facilities from investing in comprehensive shielding solutions.

Due to its increasing use in other industries, its cost is projected to increase soon. This brings up the need to develop novel raw materials. As of now, in 2022, lead costs anywhere around 600-700 USD.

Hence, the increasing cost of lead will challenge the medical radiation shielding industry during the forecast period.

Medical Radiation Shielding Market Ecosystem

Prominent companies in this market include well-established manufacturers of market and offer a wide range of products. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include ESCO Technologies, Mirion Technology, and Nelco Worldwide.

Medical Radiation Shielding Market Ecosystem

In 2022, MRI Shielding Products segment to observe highest growth rate of the medical radiation shielding industry, by type.

Based on the products, the medical radiation shielding market is categorized into MRI Shielding Products, Shields, Barriers, Booths, X-ray rooms, Lead Sheets, Lead Bricks, Lead Curtains, and Screens, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls and Plywood, High Density Concrete Blocks and Lead Acrylic. MRI Shielding Products are expected to grow fastest due to the increasing number of diagnostic imaging centers and installation base of radiology equipment and an increasing number of trained radiologic technologists. For instance, In Europe, Germany has the highest number of MRI units. In 2021, the country had the third-highest number of MRI units per million inhabitants after Japan and the US (Source: OECD 2022). According to Statista 2022, there are 35 MRI units per million population as of 2020. A large number of diagnostic imaging centers, coupled with the rising volume of examinations and strong healthcare system in terms of infrastructure, hospital beds, and trained staff, are likely to support the growth of the radiation detection, monitoring, and safety market in Germany.

In 2022, Hospitals, Clinics, and Ambulatory Surgery Centers segment to dominate the medical radiation shielding industry, by the end user.

Based on end users, the medical radiation shielding market is segmented into Hospitals, Clinics, Ambulatory Surgery Centers, and Diagnostic centers. Hospitals, Clinics, and Ambulatory Surgery Centers dominate the market due to the increasing number of cancer populations, which will increase the demand for the rising number of hospitals and diagnostic centers. Therefore, Hospitals are the largest end-users owing to the rising number of cancer patients, an increasing number of internal radiation therapy procedures, and the growing adoption of nuclear medicine, radiotherapy, and diagnostics procedures.

Medical Radiation Shielding Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global Medical Radiation Shielding market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to rise at the highest CAGR due to the rising incidence of cancer and the use of radiation therapy for diagnosis and treatment. For Instance, National expenditures associated with cancer have been steadily increasing in the US. According to a report published by ACS (in October 2020), cancer patients in the US paid USD 5.6 billion out-of-pocket for cancer treatments, including surgical procedures, radiation treatments, and chemotherapy drugs, in 2018. Approximately USD 183 billion was spent in the US on cancer-related healthcare in 2015, and this figure is projected to grow to USD 222.2 billion by 2025 and USD 246 billion by 2030.

The Medical Radiation Shielding market is dominated by players such ESCO Technologies Inc. (US), Mirion Technologies Inc. (US), and Nelco  Worldwide (US).

Scope of the Medical Radiation Shielding Industry

Report Metric 

Details 

Market Revenue in 2023

$1.4 billion

Projected Revenue by 2028

$1.8 billion

Revenue Rate

Poised to Grow at a CAGR of 6.5%

Market Driver

Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment

Market Opportunity

Rising healthcare expenditure across developing countries

This research report categorizes the medical radiation shielding market to forecast revenue and analyze trends in each of the following submarkets:


By Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

By Product

  • MRI Shielding Products        
  • Lead Lined Glass, Doors & Windows
  • Lead Lined Drywalls & Plywood        
  • Shields, Barriers, Booths      
  • Lead Sheet
  • Lead Bricks
  • High-Density Concrete Blocks            
  • X-ray Rooms             
  • Lead Curtains & Screens      
  • Lead Acrylic                                                               

By Solution

  • Diagnostic Shielding
    •  X-ray
    •  MRI
    •  CT scanners
    •  Nuclear Imaging
  • Radiation Therapy Shielding
    •  Linear Accelerator
    •  Multimodality
    •  Cyclotron
    •  Brachytherapy
    •  Proton Therapy

By End User

  • Hospitals and Clinics & ASCs
  • Diagnostic Centers

Recent Developments of Medical Radiation Shielding Industry

  • In September 2022, ESCO Technologies partnered with IMRIS, Deerfield Imaging, on a state-of-the-art MRI facility at Boston Children’s Hospital located in Boston, Massachusetts.  The newly opened Hale Family building will provide diagnostic and treatment capabilities using IMRIS’ unique on-demand intraoperative MRI (iMRI) during surgery.
  • In January 2021, Mirion Technologies acquired Sun Nuclear Corporation to strengthen its position in the market.
  • In  September 2020, Mirion acquired Biodex Medical Systems, a leader in the medical industry that offers nuclear medicine instruments, medical imaging equipment, and rehabilitation systems.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 24)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 MEDICAL RADIATION SHIELDING MARKET SEGMENTATION
           1.3.2 GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 MARKET STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 29)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 GROWTH FORECAST
                    FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                    FIGURE 7 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 ASSUMPTIONS 
    2.6 INDICATORS AND ASSUMPTIONS 
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT
    2.8 IMPACT OF RECESSION: MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 9 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 MEDICAL RADIATION SHIELDING INDUSTRY, BY SOLUTION, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 MARKET FOR RADIATION THERAPY SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET FOR DIAGNOSTIC SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 MEDICAL RADIATION SHIELDING MARKET OVERVIEW 
          FIGURE 15 GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: MARKET, BY SOLUTION AND COUNTRY, 2022 
          FIGURE 16 DIAGNOSTIC SHIELDING HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 MEDICAL RADIATION SHIELDING INDUSTRY: GEOGRAPHIC SNAPSHOT 
          FIGURE 17 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 18 MEDICAL RADIATION SHIELDING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment
                    5.2.1.2 Growing incidence of cancer
                                TABLE 2 NUMBER OF NEW CANCER CASES, 2020–2040
                                TABLE 3 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
                    5.2.1.3 Increasing safety awareness among people working in radiation-prone environments
                    5.2.1.4 Growth in number of PET/CT scans
                                TABLE 4 CT SCANNERS INSTALLED, BY COUNTRY, 2019 VS. 2021 (PER MILLION INHABITANTS)
                                TABLE 5 CT SCAN PROCEDURAL VOLUME, BY COUNTRY, 2019 VS. 2021 (PER 1,000 INHABITANTS)
                    5.2.1.5 Increasing number of trained radiologic technologists
                                TABLE 6 METROPOLITAN AREAS IN US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of adequate healthcare infrastructure
                    5.2.2.2 Shortage of skilled oncologists/radiologists
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising healthcare expenditure across developing countries
                    5.2.3.2 Increasing public-private investments in cancer research
                    5.2.3.3 Technological advancements in radiation detection
           5.2.4 CHALLENGES
                    5.2.4.1 High cost of lead in manufacturing radiation accessories
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.4 SUPPLY CHAIN ANALYSIS 
          FIGURE 20 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
    5.5 PORTER’S FIVE FORCES ANALYSIS 
           5.5.1 THREAT OF NEW ENTRANTS
           5.5.2 THREAT OF SUBSTITUTES
           5.5.3 BARGAINING POWER OF BUYERS
           5.5.4 BARGAINING POWER OF SUPPLIERS
           5.5.5 INTENSITY OF COMPETITIVE RIVALRY
    5.6 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
                    TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)
           5.6.2 BUYING CRITERIA
                    FIGURE 22 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
                    TABLE 8 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
    5.7 REGULATORY LANDSCAPE 
           5.7.1 NORTH AMERICA
           5.7.2 EUROPE
           5.7.3 ASIA PACIFIC
    5.8 TRADE ANALYSIS 
          TABLE 9 IMPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 10 EXPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)
    5.9 ECOSYSTEM ANALYSIS 
          FIGURE 23 KEY PLAYERS OPERATING IN MARKET
          TABLE 11 ROLE IN ECOSYSTEM
    5.10 PATENT ANALYSIS 
    5.11 KEY CONFERENCES & EVENTS IN 2023–2024 
           TABLE 12 LIST OF CONFERENCES & EVENTS
    5.12 PRICING ANALYSIS 
           5.12.1 AVERAGE SELLING PRICE OF KEY PRODUCTS
                     TABLE 13 PRICE RANGE OF KEY PRODUCTS IN MARKET (USD)
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.14 TECHNOLOGY ANALYSIS 
 
6 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT (Page No. - 72)
    6.1 INTRODUCTION 
          TABLE 14 MEDICAL RADIATION SHIELDING INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 MRI SHIELDING PRODUCTS 
           6.2.1 INCREASING INSTALLATION BASE OF MRI SCANNERS WORLDWIDE TO BOOST MARKET
                    TABLE 15 MARKET FOR MRI SHIELDING PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
    6.3 LEAD-LINED GLASS, DOORS, AND WINDOWS 
           6.3.1 ABILITY OF LEAD-LINED GLASS TO PROTECT PERSONNEL FROM UNNECESSARY RADIATION EXPOSURE TO PROPEL GROWTH
                    TABLE 16 MARKET FOR LEAD-LINED GLASS, DOORS, AND WINDOWS, BY REGION, 2021–2028 (USD MILLION)
    6.4 LEAD-LINED DRYWALLS & PLYWOOD 
           6.4.1 GROWING DEMAND FOR LEAD-LINED PLYWOOD FOR HEAVIER LEAD SHIELDING REQUIREMENTS TO BOOST MARKET
                    TABLE 17 MARKET FOR LEAD-LINED DRYWALLS & PLYWOOD, BY REGION, 2021–2028 (USD MILLION)
    6.5 SHIELDS, BARRIERS, AND BOOTHS 
           6.5.1 INCREASING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO DRIVE GROWTH
                    TABLE 18 MARKET FOR SHIELDS, BARRIERS, AND BOOTHS, BY REGION, 2021–2028 (USD MILLION)
    6.6 LEAD SHEETS 
           6.6.1 CORROSION RESISTANCE ASSOCIATED WITH LEAD SHEETS TO FUEL DEMAND
                    TABLE 19 MARKET FOR LEAD SHEETS, BY REGION, 2021–2028 (USD MILLION)
    6.7 LEAD BRICKS 
           6.7.1 RESISTANCE TO DAMAGE TO DRIVE ADOPTION OF LEAD BRICKS
                    TABLE 20 MARKET FOR LEAD BRICKS, BY REGION, 2021–2028 (USD MILLION)
    6.8 HIGH-DENSITY CONCRETE BLOCKS 
           6.8.1 SIGNIFICANT ATTENUATION PROVIDED BY HIGH-DENSITY CONCRETE BLOCKS TO BOOST DEMAND
                    TABLE 21 MARKET FOR HIGH-DENSITY CONCRETE BLOCKS, BY REGION, 2021–2028 (USD MILLION)
    6.9 X-RAY ROOMS 
           6.9.1 DEVELOPMENT OF NEW MATERIALS AS ALTERNATIVES TO LEAD TO CREATE GROWTH OPPORTUNITIES
                    TABLE 22 MARKET FOR X-RAY ROOMS, BY REGION, 2021–2028 (USD MILLION)
    6.10 LEAD CURTAINS & SCREENS 
           6.10.1 GREATER SHIELDING CAPABILITY OF THICK LEAD SCREENS TO FAVOR MARKET GROWTH
                     TABLE 23 MARKET FOR LEAD CURTAINS & SCREENS, BY REGION, 2021–2028 (USD MILLION)
    6.11 LEAD ACRYLIC 
           6.11.1 SUPERIOR VISUAL CLARITY AND HIGH LIGHT TRANSMISSION OF LEAD ACRYLIC TO FUEL ADOPTION
                     TABLE 24 MARKET FOR LEAD ACRYLIC, BY REGION, 2021–2028 (USD MILLION)
 
7 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION (Page No. - 85)
    7.1 INTRODUCTION 
          TABLE 25 MEDICAL RADIATION SHIELDING INDUSTRY, BY SOLUTION, 2021–2028 (USD MILLION)
    7.2 RADIATION THERAPY SHIELDING 
          TABLE 26 RADIATION THERAPY SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 27 RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
           7.2.1 LINEAR ACCELERATORS
                    7.2.1.1 Growing adoption of linear accelerators to drive market growth
                                TABLE 28 MARKET FOR LINEAR ACCELERATORS, BY REGION, 2021–2028 (USD MILLION)
           7.2.2 MULTIMODALITY IMAGING
                    7.2.2.1 Recent advances in multimodality imaging to boost market
                                TABLE 29 MARKET FOR MULTIMODALITY IMAGING, BY REGION, 2021–2028 (USD MILLION)
           7.2.3 CYCLOTRONS
                    7.2.3.1 Ability of cyclotrons to produce high yields of short half-life, neutron-deficient radioisotopes to favor market growth
                                TABLE 30 MARKET FOR CYCLOTRONS, BY REGION, 2021–2028 (USD MILLION)
           7.2.4 BRACHYTHERAPY
                    7.2.4.1 Ability of brachytherapy to deliver low-dose radiation to drive market
                                TABLE 31 MARKET FOR BRACHYTHERAPY, BY REGION, 2021–2028 (USD MILLION)
           7.2.5 PROTON THERAPY
                    7.2.5.1 Non-invasive and non-threatening nature of proton therapy to fuel adoption
                                TABLE 32 MARKET FOR PROTON THERAPY, BY REGION, 2021–2028 (USD MILLION)
    7.3 DIAGNOSTIC SHIELDING 
          TABLE 33 DIAGNOSTIC SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 34 DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
           7.3.1 CT SCANNERS
                    7.3.1.1 Rising demand for CT systems from hospitals, clinics, and ASCs to drive market
                                TABLE 35 MARKET FOR CT SCANNERS, BY REGION, 2021–2028 (USD MILLION)
           7.3.2 X-RAY IMAGING
                    7.3.2.1 Consistent high quality of images provided by digital imaging to boost demand
                                TABLE 36 MARKET FOR X-RAY IMAGING, BY REGION, 2021–2028 (USD MILLION)
           7.3.3 MRI
                    7.3.3.1 Wide use of MRI in hospitals for medical diagnosis and staging of diseases to boost growth
                                TABLE 37 MARKET FOR MRI, BY REGION, 2021–2028 (USD MILLION)
           7.3.4 NUCLEAR IMAGING
                    7.3.4.1 Recent advances in nuclear medicine to increase number of nuclear medicine procedures globally
                                TABLE 38 MARKET FOR NUCLEAR MEDICINE, BY REGION, 2021–2028 (USD MILLION)
 
8 MEDICAL RADIATION SHIELDING MARKET, BY END USER (Page No. - 98)
    8.1 INTRODUCTION 
          TABLE 39 MEDICAL RADIATION SHIELDING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    8.2 HOSPITALS, ASCS, AND CLINICS 
           8.2.1 INCREASING NUMBER OF INTERNAL RADIATION THERAPY PROCEDURES TO BOOST MARKET GROWTH
                    TABLE 40 MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION)
    8.3 DIAGNOSTIC CENTERS 
           8.3.1 GROWING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE GROWTH
                    TABLE 41 MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
 
9 MEDICAL RADIATION SHIELDING MARKET, BY REGION (Page No. - 102)
    9.1 INTRODUCTION 
          TABLE 42 MEDICAL RADIATION SHIELDING INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT
                    TABLE 43 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 44 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 45 NORTH AMERICA: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                    TABLE 46 NORTH AMERICA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 47 NORTH AMERICA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 48 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.2 US
                    9.2.2.1 US to dominate North American medical radiation shielding market during forecast period
                                TABLE 49 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 50 US: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 51 US: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 52 US: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 53 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Increasing number of radiography procedures to support market growth in Canada
                                TABLE 54 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 55 CANADA: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 56 CANADA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 57 CANADA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 58 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 59 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 60 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 61 EUROPE: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                    TABLE 62 EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 63 EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 64 EUROPE: MEDICAL RADIATION SHIELDING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Growing geriatric population and increasing radiography procedures in Germany to favor market growth
                                TABLE 65 GERMANY: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 66 GERMANY: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 67 GERMANY: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 68 GERMANY: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 69 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Large number of CT procedures performed to fuel market
                                TABLE 70 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 71 FRANCE: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 72 FRANCE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 73 FRANCE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 74 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.4 UK
                    9.3.4.1 Increasing government initiatives and support to aid market
                                TABLE 75 UK: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 76 UK: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 77 UK: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 78 UK: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 79 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.5 REST OF EUROPE
                    TABLE 80 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 81 REST OF EUROPE: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                    TABLE 82 REST OF EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 83 REST OF EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 84 REST OF EUROPE: MEDICAL RADIATION SHIELDING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT
                    TABLE 85 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 86 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                    TABLE 88 ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 90 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Large patient pool and rising healthcare spending to aid market
                                TABLE 91 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 92 CHINA: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 93 CHINA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 94 CHINA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 95 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Rising awareness about radiation exposure to drive market
                                TABLE 96 JAPAN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 97 JAPAN: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 98 JAPAN: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 99 JAPAN: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 100 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Favorable government policies and healthcare infrastructure to support market
                                TABLE 101 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 102 INDIA: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                                TABLE 103 INDIA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 104 INDIA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 105 INDIA: MEDICAL RADIATION SHIELDING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 106 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC, 2020 VS. 2040
                    TABLE 107 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 108 REST OF ASIA PACIFIC: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                    TABLE 109 REST OF ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 110 REST OF ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 111 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.5 REST OF THE WORLD (ROW) 
           9.5.1 REST OF THE WORLD (ROW): RECESSION IMPACT
                    TABLE 112 REST OF THE WORLD: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 113 REST OF THE WORLD: MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
                    TABLE 114 REST OF THE WORLD: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 115 REST OF THE WORLD: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 116 REST OF THE WORLD: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 145)
     10.1 OVERVIEW 
             TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL RADIATION SHIELDING MARKET
     10.2 MARKET RANKING 
             TABLE 118 TOP 3 COMPANIES IN MEDICAL RADIATION SHIELDING INDUSTRY
     10.3 COMPANY EVALUATION QUADRANT FOR TOP PLAYERS 
             10.3.1 STARS
             10.3.2 EMERGING LEADERS
             10.3.3 PARTICIPANTS
             10.3.4 PERVASIVE PLAYERS
                        FIGURE 26 MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022
     10.4 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS 
             10.4.1 PROGRESSIVE COMPANIES
             10.4.2 STARTING BLOCKS
             10.4.3 RESPONSIVE COMPANIES
             10.4.4 DYNAMIC COMPANIES
                        FIGURE 27 MEDICAL RADIATION SHIELDING INDUSTRY: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
     10.5 COMPETITIVE BENCHMARKING 
             TABLE 119 MEDICAL RADIATION SHIELDING INDUSTRY: DETAILED LIST OF KEY STARTUPS/SMES
     10.6 COMPANY FOOTPRINT ANALYSIS 
             TABLE 120 FOOTPRINT ANALYSIS OF COMPANIES
             TABLE 121 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
             TABLE 122 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
     10.7 COMPETITIVE SCENARIO 
             10.7.1 DEALS
                        TABLE 123 KEY DEALS, JANUARY 2020–MAY 2023
             10.7.2 OTHER DEVELOPMENTS
                        TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020–MAY 2023
 
11 COMPANY PROFILES (Page No. - 156)
     11.1 KEY PLAYERS 
(Business overview, Products offered, Recent Developments, MNM view)*
             11.1.1 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY)
                        TABLE 125 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): BUSINESS OVERVIEW
                        FIGURE 28 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): COMPANY SNAPSHOT (2022)
             11.1.2 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.)
                        TABLE 126 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): BUSINESS OVERVIEW
                        FIGURE 29 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): COMPANY SNAPSHOT (2022)
             11.1.3 NELCO WORLDWIDE
                        TABLE 127 NELCO WORLDWIDE: BUSINESS OVERVIEW
             11.1.4 GAVEN INDUSTRIES, INC.
                        TABLE 128 GAVEN INDUSTRIES, INC.: BUSINESS OVERVIEW
             11.1.5 RADIATION PROTECTION PRODUCTS, INC.
                        TABLE 129 RADIATION PROTECTION PRODUCTS, INC.: BUSINESS OVERVIEW
             11.1.6 MARSHIELD (A DIVISION OF MARS METAL CO.)
                        TABLE 130 MARSHIELD (A DIVISION OF MARS METAL CO.): BUSINESS OVERVIEW
             11.1.7 RAY-BAR ENGINEERING CORP.
                        TABLE 131 RAY-BAR ENGINEERING CORP.: BUSINESS OVERVIEW
             11.1.8 AMRAY MEDICAL
                        TABLE 132 AMRAY MEDICAL: BUSINESS OVERVIEW
             11.1.9 A&L SHIELDING
                        TABLE 133 A&L SHIELDING: BUSINESS OVERVIEW
             11.1.10 GLOBAL PARTNERS IN SHIELDING, INC.
                        TABLE 134 GLOBAL PARTNERS IN SHIELDING, INC.: BUSINESS OVERVIEW
             11.1.11 VERITAS MEDICAL SOLUTIONS LLC
                        TABLE 135 VERITAS MEDICAL SOLUTIONS, LLC: BUSINESS OVERVIEW
             11.1.12 ALIMED, INC.
                        TABLE 136 ALIMED, INC.: BUSINESS OVERVIEW
             11.1.13 PROTECH MEDICAL
                        TABLE 137 PROTECH MEDICAL: BUSINESS OVERVIEW
             11.1.14 GLOBE COMPOSITE SOLUTIONS LLC
                        TABLE 138 GLOBE COMPOSITE SOLUTIONS LLC: BUSINESS OVERVIEW
             11.1.15 ULTRARAY
                        TABLE 139 ULTRARAY: BUSINESS OVERVIEW
             11.1.16 MARS METAL COMPANY
                        TABLE 140 MARS METAL COMPANY: BUSINESS OVERVIEW
             11.1.17 NUCLEAR LEAD CO.
                        TABLE 141 NUCLEAR LEAD CO.: BUSINESS OVERVIEW
             11.1.18 NUCLEAR SHIELDS B.V.
                        TABLE 142 NUCLEAR SHIELDS B.V.: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS 
             11.2.1 SHIELDING INTERNATIONAL INC.
             11.2.2 BAR-RAY PRODUCTS, INC.
             11.2.3 XENA SHIELD
             11.2.4 BURLINGTON MEDICAL
             11.2.5 SIMAD SRL
             11.2.6 EUROPEAN EMC PRODUCTS
 
12 APPENDIX (Page No. - 192)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Medical radiation shielding market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Medical radiation shielding market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the Medical radiation shielding market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as Hospitals and Clinics & ASCs) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 45% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 55%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants

Medical Radiation Shielding Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

 ESCO Technologies Inc. (US)

Regional Manager

Mirion Technologies, Inc. (US)

Senior Product Manager

Radiation Protection Products, Inc. (US)

Product Manager

Market Size Estimation

All major product manufacturers offering various Medical Radiation Shielding Markets were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value market was also split into various segments and subsegments at the regional and country levels based on the following:

  • Product mapping of various manufacturers for each solution of market at the regional and country-level 
  • Relative adoption pattern of each Medical radiation shielding market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Medical Radiation Shielding Market Size: Top-Down Approach

Medical Radiation Shielding Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Medical Radiation Shielding industry.

Market Definition

Medical radiation shielding refers to the products and solutions used to protect people from harmful radiation. Radiation shielding works on the principle of attenuation; attenuation is the ability to reduce the radiation effect by blocking it through a barrier material. Medical radiation shielding plays a crucial role in radiation therapy and diagnostic imaging.

Key Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the Medical radiation shielding market by product, application, end-user, and region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, and Rest of the world
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the market.
  • To benchmark players within the market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Medical radiation shielding market
  • Profiling of additional market players (up to 5)  Product Analysis
  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Medical radiation shielding Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 4508
Published ON
Aug, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Medical Radiation Shielding Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback